COVID-19. COVID-19, virus identified
Conditions
Interventions
Intervention 1: Intervention group: In the intervention group, in addition to receiving the national standard treatment, patients will receive oral vitamin A 25,000 international units (Zahravi-Iran)
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 75 Years
Inclusion criteria
Inclusion criteria: Having clinical signs and test results that confirm COVID-19 CRP level higher than 0.3 mg per liter Having an ESR higher than 22 mm per hour for women and 29 mm per hour for men
Exclusion criteria
Exclusion criteria: Having any autoimmune disease (lupus, MS, etc.) Suffering from diseases that interfere with the absorption of vitamin A. Consumers of vitamin A supplements Patients with severe renal insufficiency and dialysis Patients with underlying liver disease Pregnancy Lactation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical symptoms improvement. Timepoint: Before the intervention and 10 days after the start of the intervention. Method of measurement: Definition of clinical improvement includes normalization of body temperature (=37.2's,) number of breaths (= 24 breaths per minute,) oxygen saturation (> 94% at room temperature) that is stable for at least 24 hours.;Hospitalization. Timepoint: Ten days after the start of the intervention. Method of measurement: Patients' hospitalization will be recorded using a questionnaire and their follow-up.;C-reactive protein. Timepoint: Before the intervention and 10 days after the intervention. Method of measurement: Hemagglutination.;Erythrocyte Sedimentation Rate. Timepoint: Before the intervention and 10 days after the intervention. Method of measurement: Erythrocyte Sedimentation test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehdi Shokri
Arak University of Medical Sciences
Outcome results
None listed